Role of autophagy in the resistance to tumour necrosis factor-related apoptosis-inducing ligand-induced apoptosis in papillary and anaplastic thyroid cancer cells

Endocrine

Volumn 45, Issue 2, 2014, Pages 256-262

  Jin, Sang Man ^a   Jang, Hye Won ^a   Sohn, Seo Young ^a   Kim, Na Kyung ^a   Joung, Ji Young ^a   Cho, Yoon Young ^a   Kim, Sun Wook ^a   Chung, Jae Hoon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Apoptosis; Autophagy; Thyroid cancer; TRAIL

Indexed keywords

CASPASE 3; MEMBRANE PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN ATG7; PROTEIN LC3; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANAPLASTIC THYROID CANCER; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIZATION; HUMAN; HUMAN CELL; PAPILLARY THYROID CANCER; PRIORITY JOURNAL; THYROID CANCER;

APOPTOSIS; AUTOPHAGY; CARCINOMA; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; GENE KNOCKDOWN TECHNIQUES; HUMANS; RNA, SMALL INTERFERING; THYROID NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UBIQUITIN-ACTIVATING ENZYMES;

EID: 84896689242     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-9997-8     Document Type: Article

References (18)

1. C. Conticello, L. Adamo, R. Giuffrida, L. Vicari, A. Zeuner, A. Eramo, G. Anastasi, L. Memeo, D. Giuffrida, G. Iannolo et al., Proteasome inhibitors synergize with tumor necrosis factor-related apoptosis-induced ligand to induce anaplastic thyroid carcinoma cell death. J. Clin. Endocrinol. Metab. 92, 1938-1942 (2007)
2. J.Y. Guo, H.Y. Chen, R. Mathew, J. Fan, A.M. Strohecker, G. Karsli-Uzunbas, J.J. Kamphorst, G. Chen, J.M. Lemons, V. Karantza et al., Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 25, 460-470 (2011)
3. W. Hou, J. Han, C. Lu, L.A. Goldstein, H. Rabinowich, Autophagic degradation of active caspase-8: a crosstalk mechanism between autophagy and apoptosis. Autophagy 6, 891-900 (2010)
4. R.W. Johnstone, A.J. Frew, M.J. Smyth, The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat. Rev. Cancer 8, 782-798 (2008)
5. V. Langaas, S. Shahzidi, J.I. Johnsen, B. Smedsrod, B. Sveinbjornsson, Interferon-gamma modulates TRAIL-mediated apoptosis in human colon carcinoma cells. Anticancer Res. 21, 3733-3738 (2001)
6. L.C. Li, S. Jayarama, T. Pilli, L. Qian, F. Pacini, B.S. Prabhakar, Down-modulation of expression, or dephosphorylation, of IG20/MADD in tumor necrosis factor-related apoptosis-inducing ligand-resistant thyroid cancer cells makes them susceptible to treatment with this ligand. Thyroid 23, 70-78 (2013)
7. C.I. Lin, E.E. Whang, D.B. Donner, J. Du, J. Lorch, F. He, X. Jiang, B.D. Price, F.D. Moore Jr., D.T. Ruan, Autophagy induction with RAD001 enhances chemosensitivity and radiosensitivity through Met inhibition in papillary thyroid cancer. Mol. Cancer Res. 8, 1217-1226 (2010)
8. J.S. Long, K.M. Ryan, New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy. Oncogene 31, 5045-5060 (2012)
9. N. Mitsiades, V. Poulaki, S. Tseleni-Balafouta, D.A. Koutras, I. Stamenkovic, Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res. 60, 4122-4129 (2000)
10. A. Munshi, T.J. McDonnell, R.E. Meyn, Chemotherapeutic agents enhance TRAIL-induced apoptosis in prostate cancer cells. Cancer Chemother. Pharmacol. 50, 46-52 (2002)
11. J.W. Park, M.G. Wong, M. Lobo, W.C. Hyun, Q.Y. Duh, O.H. Clark, Modulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by chemotherapy in thyroid cancer cell lines. Thyroid 13, 1103-1110 (2003)
12. K.J. Park, S.H. Lee, T.I. Kim, H.W. Lee, C.H. Lee, E.H. Kim, J.Y. Jang, K.S. Choi, M.H. Kwon, Y.S. Kim, A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells. Cancer Res. 67, 7327-7334 (2007)
13. J.C. Soria, Z. Mark, P. Zatloukal, B. Szima, I. Albert, E. Juhasz, J.L. Pujol, J. Kozielski, N. Baker, D. Smethurst et al., Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer. J. Clin. Oncol. 29, 4442-4451 (2011)
14. M. Subramanian, T. Pilli, P. Bhattacharya, F. Pacini, Y.E. Nikiforov, P.V. Kanteti, B.S. Prabhakar, Knockdown of IG20 gene expression renders thyroid cancer cells susceptible to apoptosis. J. Clin. Endocrinol. Metab. 94, 1467-1471 (2009)
15. H. Walczak, R.E. Miller, K. Ariail, B. Gliniak, T.S. Griffith, M. Kubin, W. Chin, J. Jones, A. Woodward, T. Le et al., Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 5, 157-163 (1999)
16. Z.X. Xu, J. Liang, V. Haridas, A. Gaikwad, F.P. Connolly, G.B. Mills, J.U. Gutterman, A plant triterpenoid, avicin D, induces autophagy by activation of AMP-activated protein kinase. Cell Death Differ. 14, 1948-1957 (2007)
17. L.Y. Xue, S.M. Chiu, N.L. Oleinick, Atg7 deficiency increases resistance of MCF-7 human breast cancer cells to photodynamic therapy. Autophagy 6, 248-255 (2010)
18. S. Yang, X. Wang, G. Contino, M. Liesa, E. Sahin, H. Ying, A. Bause, Y. Li, J.M. Stommel, G. Dell'antonio et al., Pancreatic cancers require autophagy for tumor growth. Genes Dev. 25, 717-729 (2011)